Registration - In-house Corporation

Abbott Laboratories Co. / Luz Herrera, General Manager - Canada, Abbott Diabetes Care

Registration Information

In-house Corporation name: Abbott Laboratories Co.
Previous in-house corporation names
Responsible Officer Name: Luz Herrera, General Manager - Canada, Abbott Diabetes Care
Responsible Officer Change History
Initial registration start date: 2005-08-25
Registration status: Active
Registration Number: 955225-5310

Associated Communications

Total Number of Communication Reports: 19

Monthly communication reports in the last 6 months: 0

Version 5 of 27 (2018-11-16 to 2019-02-06)

Registration versions:

Version 5 of 27 (2018-11-16 to 2019-02-06)

Lobbying Information

Subject Matters

Health

Subject Matter Details

Policies or Program

Manufacturing site visit to improve understanding of manufacturing process and quality controls, to improve reviews of infant formula submissions.
Working with Food & Consumer Products of Canada (FCPC) Infant Formula cluster to improve the overall process for premarket notification and obtain faster, more predictable approvals.

Communication Techniques

Written communication
Oral communication

Government Institutions

Health Canada (HC)

In-house Corporation Details

Description of activities

Abbott is a broad-based health care company that discovers, develops, manufactures and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, and nutritionals for children and adults.

Responsible officer name and position during the period of this registration

Matthew Harris, General Manager, Abbott Nutrition Division

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
8401 TransCanada Highway
Saint-Laurent, QC H4S 1Z1
Canada

Telephone number: 514-832-7200

Parent Company Information

Abbott Laboratories
- 100 Abbott Park Rd
  Abbott Park, IL 60064-3500
  United States of America

Subsidiary Beneficiary Information

Abbott Laboratories, Limited does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Matthew Harris, General Manager, Abbott Nutrition Division | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Genevieve D'Annunzio, Manager, Regulatory Affairs | No public offices held

Abbott Laboratories Co./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Abbott Laboratories Co./	2024-06-19	current
Abbott Laboratories Co./	2020-01-01	2024-06-19
Abbott Laboratories, Limited	2018-07-31	2020-01-01

The following names have been used before July 2, 2008

Abbott Laboratories, Limited

Abbott Laboratories Co.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Luz Herrera	2023-06-09	Current
Maria Karounis	2023-03-27	2023-06-09
Philippe Busque	2022-06-20	2023-03-27
Matthew Harris	2018-07-31	2022-06-20
Marcelo Vizio	2005-08-25	2007-04-25

Luz Herrera, General Manager - Canada, Abbott Diabetes Care (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-19 of 19

Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sarah Thomas, Policy Advisor | Office of the Deputy Prime Minister & Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2023-02-03
Posted date: 2023-03-15
Communication number: 5310-557602 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Brewster, Director, Parliamentary Affairs | Environment and Climate Change Canada (ECCC)
Subject Matter of the communication: Health
Communication date: 2023-01-27
Posted date: 2023-02-15
Communication number: 5310-555429 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- François-Olivier Picard, Policy advisor | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-12-15
Posted date: 2023-01-16
Communication number: 5310-552880 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nicolas Thibodeau, Parliamentary Affairs and Policy Advisor | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2022-11-24
Posted date: 2022-12-15
Communication number: 5310-548742 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helen Gao, A/Chief of Staff | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2022-07-26
Posted date: 2022-08-15
Communication number: 5310-539143 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Vance Badawey, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-04-26
Posted date: 2022-05-16
Communication number: 5310-530658 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helen Gao, Director of Policy | Minister's Office | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2022-03-31
Posted date: 2022-04-16
Communication number: 5310-527712 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jaime Battiste, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-03-31
Posted date: 2022-04-16
Communication number: 5310-527711 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Brewster, Director of Policy | Minister's Office | Environment and Climate Change Canada (ECCC)
- Kurtis Layden, Parliamentary Affairs and Policy Advisor | Minister's Office | Environment and Climate Change Canada (ECCC)
Subject Matter of the communication: Health
Communication date: 2022-03-28
Posted date: 2022-04-16
Communication number: 5310-527707 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- François-Olivier Picard, Policy Advisor | Minister's Office, Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-03-01
Posted date: 2022-04-06
Communication number: 5310-527706 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mike Kelloway, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-02-18
Posted date: 2022-03-15
Communication number: 5310-524022 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-05-27
Posted date: 2021-06-15
Communication number: 5310-507142 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Keith Conn, Acting Assistant Deputy Minister | First Nations and Inuit Health Branch | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2020-06-18
Posted date: 2020-07-10
Communication number: 5310-476811 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Vandergrift, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
- Arianne Reza, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
Subject Matter of the communication: Health
Communication date: 2020-05-15
Posted date: 2020-06-12
Communication number: 5310-474949 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kim Elmslie, Vice President | Public Health Agency of Canada (PHAC)
- Arianne Reza, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)
Subject Matter of the communication: Health
Communication date: 2020-05-14
Posted date: 2020-06-12
Communication number: 5310-474948 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tina Namiesniowski, President | Public Health Agency of Canada (PHAC)
- Kim Elmslie, Vice President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2020-05-13
Posted date: 2020-06-12
Communication number: 5310-474947 (amended from 5310-474946) View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Supriya Sharma, Chief Medical Advisor, HC / Senior Medical Advisor for HPFB | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-04-07
Posted date: 2020-04-17
Communication number: 5310-471366 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steven Guercio, Executive Director | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2020-03-31
Posted date: 2020-04-07
Communication number: 5310-469456 View associated registration
Abbott Laboratories Co.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frédéric Seppey, Assistant Deputy Minister | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Health
Communication date: 2019-04-17
Posted date: 2019-05-14
Communication number: 5310-452103 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Abbott Laboratories Co. / Luz Herrera, General Manager - Canada, Abbott Diabetes Care

Registration Information

Associated Communications

Version 5 of 27 (2018-11-16 to 2019-02-06)

Version 5 of 27 (2018-11-16 to 2019-02-06)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties